Home > AMGN Analysis

Is Amgen Inc. (AMGN) Undervalued?

Based on the current stock price of $332.93 and a P/E ratio of 25.77,Amgen Inc. has a PEG ratio of 3.64.

The Short Answer:

Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of 3.64, AMGN appears to be potentially overvalued relative to its growth rate of 7.08%.

Valuation Status
Overvalued

Based on a PEG ratio of 2.58 (adjusted for dividends).

01.02.0+
P/E Ratio
25.77
Growth Rate
7.08%
Stock Price
$332.93
Market Cap
179276349440

Compare AMGN vs Competitors

Use the calculator below to see how AMGN stacks up against other stocks in the same industry.

Analyze Any Stock

Get instant P/E, PEG, and PEGY ratios with real-time data

💡 Try popular stocks: AAPL, MSFT, GOOGL, TSLA, AMZN, NVDA, META

How we analyzed AMGN

We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 25.77and dividing it by the annual growth rate of 7.08%.

PEG = 25.77 (P/E) ÷ 7.08 (Growth) = 3.64

Frequently Asked Questions about AMGN

What is the current PEG Ratio for Amgen Inc. (AMGN)?+

The current PEG Ratio for Amgen Inc. is 3.64. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.

Is AMGN stock undervalued right now?+

Based on the PEG ratio of 3.64, Amgen Inc. appears to be potentially overvalued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.

What is the PEGY Ratio for AMGN?+

The PEGY ratio for Amgen Inc. is 2.58. This metric accounts for dividend yield (2.90%), providing a more complete valuation picture.